Cargando…
Biological investigations on therapeutic effect of chitosan encapsulated nano resveratrol against gestational diabetes mellitus rats induced by streptozotocin
The chitosan encapsulation with bioactive compounds (resveratrol) is a significant method that can be used to raise the stability and effectiveness of substances in gestational diabetes management. In this study, the resveratrol–zinc oxide complex is encapsulated with chitosan (CS–ZnO–RS). The synth...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216480/ https://www.ncbi.nlm.nih.gov/pubmed/32611265 http://dx.doi.org/10.1080/10717544.2020.1775722 |
_version_ | 1783710427814821888 |
---|---|
author | Du, Shengye Lv, Yan Li, Na Huang, Xianxia Liu, Xuemei Li, Hui Wang, Chao Jia, Yi-Fang |
author_facet | Du, Shengye Lv, Yan Li, Na Huang, Xianxia Liu, Xuemei Li, Hui Wang, Chao Jia, Yi-Fang |
author_sort | Du, Shengye |
collection | PubMed |
description | The chitosan encapsulation with bioactive compounds (resveratrol) is a significant method that can be used to raise the stability and effectiveness of substances in gestational diabetes management. In this study, the resveratrol–zinc oxide complex is encapsulated with chitosan (CS–ZnO–RS). The synthesized CS–ZnO–RS could be used to deliver the resveratrol with minimized side effects and also improved bioavailability. CS–ZnO–RS were characterized by various techniques such as particle size analyzer, DSC, FT-IR, TEM, SEM, and AFM. The electron microscopic and particle analyzer confirmed that the synthesized CS–ZnO–RS were monodispersed, spherical and its average size was 38 nm. The drug-releasing profile showed that 95% of RS is released from CS–ZnO–RS within 24 h. In vitro studies confirmed that α-glucosidase and α-amylase inhibitory activities were closely related to the concentration of CS–ZnO–RS. The highest inhibition of α-glucosidase (77.32%) and α-amylase (78.4%) was observed at 500 μg/mL. Furthermore, the treatment of CS–ZnO–RS significantly decreased the blood glucose levels in gestational diabetes mellitus induced rats and maintained the lipid content toward the normal rats. In addition, the CS–ZnO–RS reduced the level of inflammation factors (IL-6 and MCP-1) and endoplasmic reticulum stress (GRP78, p-IRE1α, p-eIF2α, and p-PERK). |
format | Online Article Text |
id | pubmed-8216480 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-82164802021-07-06 Biological investigations on therapeutic effect of chitosan encapsulated nano resveratrol against gestational diabetes mellitus rats induced by streptozotocin Du, Shengye Lv, Yan Li, Na Huang, Xianxia Liu, Xuemei Li, Hui Wang, Chao Jia, Yi-Fang Drug Deliv Research Article The chitosan encapsulation with bioactive compounds (resveratrol) is a significant method that can be used to raise the stability and effectiveness of substances in gestational diabetes management. In this study, the resveratrol–zinc oxide complex is encapsulated with chitosan (CS–ZnO–RS). The synthesized CS–ZnO–RS could be used to deliver the resveratrol with minimized side effects and also improved bioavailability. CS–ZnO–RS were characterized by various techniques such as particle size analyzer, DSC, FT-IR, TEM, SEM, and AFM. The electron microscopic and particle analyzer confirmed that the synthesized CS–ZnO–RS were monodispersed, spherical and its average size was 38 nm. The drug-releasing profile showed that 95% of RS is released from CS–ZnO–RS within 24 h. In vitro studies confirmed that α-glucosidase and α-amylase inhibitory activities were closely related to the concentration of CS–ZnO–RS. The highest inhibition of α-glucosidase (77.32%) and α-amylase (78.4%) was observed at 500 μg/mL. Furthermore, the treatment of CS–ZnO–RS significantly decreased the blood glucose levels in gestational diabetes mellitus induced rats and maintained the lipid content toward the normal rats. In addition, the CS–ZnO–RS reduced the level of inflammation factors (IL-6 and MCP-1) and endoplasmic reticulum stress (GRP78, p-IRE1α, p-eIF2α, and p-PERK). Taylor & Francis 2020-07-02 /pmc/articles/PMC8216480/ /pubmed/32611265 http://dx.doi.org/10.1080/10717544.2020.1775722 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Du, Shengye Lv, Yan Li, Na Huang, Xianxia Liu, Xuemei Li, Hui Wang, Chao Jia, Yi-Fang Biological investigations on therapeutic effect of chitosan encapsulated nano resveratrol against gestational diabetes mellitus rats induced by streptozotocin |
title | Biological investigations on therapeutic effect of chitosan encapsulated nano resveratrol against gestational diabetes mellitus rats induced by streptozotocin |
title_full | Biological investigations on therapeutic effect of chitosan encapsulated nano resveratrol against gestational diabetes mellitus rats induced by streptozotocin |
title_fullStr | Biological investigations on therapeutic effect of chitosan encapsulated nano resveratrol against gestational diabetes mellitus rats induced by streptozotocin |
title_full_unstemmed | Biological investigations on therapeutic effect of chitosan encapsulated nano resveratrol against gestational diabetes mellitus rats induced by streptozotocin |
title_short | Biological investigations on therapeutic effect of chitosan encapsulated nano resveratrol against gestational diabetes mellitus rats induced by streptozotocin |
title_sort | biological investigations on therapeutic effect of chitosan encapsulated nano resveratrol against gestational diabetes mellitus rats induced by streptozotocin |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216480/ https://www.ncbi.nlm.nih.gov/pubmed/32611265 http://dx.doi.org/10.1080/10717544.2020.1775722 |
work_keys_str_mv | AT dushengye biologicalinvestigationsontherapeuticeffectofchitosanencapsulatednanoresveratrolagainstgestationaldiabetesmellitusratsinducedbystreptozotocin AT lvyan biologicalinvestigationsontherapeuticeffectofchitosanencapsulatednanoresveratrolagainstgestationaldiabetesmellitusratsinducedbystreptozotocin AT lina biologicalinvestigationsontherapeuticeffectofchitosanencapsulatednanoresveratrolagainstgestationaldiabetesmellitusratsinducedbystreptozotocin AT huangxianxia biologicalinvestigationsontherapeuticeffectofchitosanencapsulatednanoresveratrolagainstgestationaldiabetesmellitusratsinducedbystreptozotocin AT liuxuemei biologicalinvestigationsontherapeuticeffectofchitosanencapsulatednanoresveratrolagainstgestationaldiabetesmellitusratsinducedbystreptozotocin AT lihui biologicalinvestigationsontherapeuticeffectofchitosanencapsulatednanoresveratrolagainstgestationaldiabetesmellitusratsinducedbystreptozotocin AT wangchao biologicalinvestigationsontherapeuticeffectofchitosanencapsulatednanoresveratrolagainstgestationaldiabetesmellitusratsinducedbystreptozotocin AT jiayifang biologicalinvestigationsontherapeuticeffectofchitosanencapsulatednanoresveratrolagainstgestationaldiabetesmellitusratsinducedbystreptozotocin |